PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Summary

To investigate dose-response efficacy and safety in hemodialysis patients with hyperphosphatemia.

Timeline

Start

2012-01-11

Primary completion

2012-07-03

Completion

2012-07-03

Publications

• Natale P, Green SC, Ruospo M, Craig JC, Vecchio M, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev. 2025 Jun 27;6(6):CD006023. doi: 10.1002/14651858.CD006023.pub4.

Drugs

Indications